|
1
|
Johnson N, Franceschi S, Ferlay J, Ramadas
K, Schmid S, MacDonald DG, Bouquet JE and Slootweg PJ: Squamous
cell carcinoma. WHO Classification of Tumours. Pathology and
Genetics of Head and Neck Tumours. Barnes L, Eveson JW, Reichart P
and Sideransky D: IARC Press; Lyon: pp. 168–175. 2005
|
|
2
|
Katase N, Gunduz M, Beder L, Gunduz E,
Lefeuvre M, Hatipoglu OF, Borkosky SS, Tamamura R, Tominaga S,
Yamanaka N, Shimizu K, Nagai N and Nagatsuka H: Deletion at
Dickkopf (dkk)-3 locus (11p15.2) is related with lower lymph node
metastasis and better prognosis in head and neck squamous cell
carcinomas. Oncol Res. 17:273–282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katase N, Gunduz M, Beder LB, Gunduz E, Al
Sheikh Ali M, Tamamura R, Yaykasli KO, Yamanaka N, Shimizu K and
Nagatsuka H: Frequent allelic loss of Dkk-1 locus (10q11.2) is
related with low distant metastasis and better prognosis in head
and neck squamous cell carcinomas. Cancer Invest. 28:103–110. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Veeck J and Dahl E: Targeting the Wnt
pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys
Acta. 1825:18–28. 2012.PubMed/NCBI
|
|
5
|
Hoang BH, Kubo T, Healey JH, Yang R,
Nathan SS, Kolb EA, Mazza B, Meyers PA and Gorlick R: Dickkopf 3
inhibits invasion and motility of Saos-2 osteosarcoma cells by
modulating the Wnt-beta-catenin pathway. Cancer Res. 64:2734–2739.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gu YM, Ma YH, Zhao WG and Chen J:
Dickkopf3 overexpression inhibits pancreatic cancer cell growth in
vitro. World J Gastroenterol. 17:3810–3817. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abarzua F, Sakaguchi M, Takaishi M, Nasu
Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH:
Adenovirus-mediated overexpression of REIC/Dkk-3 selectively
induces apoptosis in human prostate cancer cells through activation
of c-Jun-NH2-kinase. Cancer Res. 65:9617–9622. 2005. View Article : Google Scholar
|
|
8
|
Than SS, Kataoka K, Sakaguchi M, Murata H,
Abarzua F, Taketa C, Du G, Yashiro M, Yanagihara K, Nasu Y, Kumon H
and Huh NH: Intraperitoneal administration of an adenovirus vector
carrying REIC/Dkk-3 suppresses peritoneal dissemination of
scirrhous gastric carcinoma. Oncol Rep. 25:989–995. 2011.
|
|
9
|
Sakaguchi M, Kataoka K, Abarzua F,
Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y,
Ochiai K, Nasu Y, Kumon H and Huh NH: Overexpression of REIC/Dkk-3
in normal fibroblasts suppresses tumor growth via induction of
interleukin-7. J Biol Chem. 284:14236–14244. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katase N, Lefeuvre M, Gunduz M, Gunduz E,
Beder LB, Grenman R, Fujii M, Tamamura R, Tsujigiwa H and Nagatsuka
H: Absence of Dickkopf (Dkk)-3 protein expression is correlated
with longer disease-free survival and lower incidence of metastasis
in head and neck squamous cell carcinoma. Oncol Lett. 3:273–280.
2012.PubMed/NCBI
|
|
11
|
Fujii M, Katase N, Lefeuvre M, Gunduz M,
Buery RR, Tamamura R, Tsujigiwa H and Nagatsuka H: Dickkopf (Dkk)-3
and β-catenin expressions increased in the transition from normal
oral mucosal to oral squamous cell carcinoma. J Mol Histol.
42:499–504. 2011.
|
|
12
|
Maehata T, Taniguchi H, Yamamoto H, Nosho
K, Adachi Y, Miyamoto N, Miyamoto C, Akutsu N, Yamaoka S and Itoh
F: Transcriptional silencing of Dickkopf gene family by CpG island
hypermethylation in human gastrointestinal cancer. World J
Gastroenterol. 14:2702–2714. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hughes L, Malone C, Chumsri S, Burger AM
and McDonnell S: Characterisation of breast cancer cell lines and
establishment of a novel isogenic subclone to study migration,
invasion and tumourigenicity. Clin Exp Metastasis. 25:549–557.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sato H, Suzuki H, Toyota M, Nojima M,
Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M,
Sonoda T, Mori M, Imai K, Tokino T and Shinomura Y: Frequent
epigenetic inactivation of DICKKOPF family genes in human
gastrointestinal tumors. Carcinogenesis. 28:2459–2566. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding Z, Qian YB, Zhu LX and Xiong QR:
Promoter methylation and mRNA expression of DKK-3 and WIF-1 in
hepatocellular carcinoma. World J Gastroenterol. 15:2595–2601.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Veeck J, Wild PJ, Fuchs T, Schüffler PJ,
Hartmann A, Knüchel R and Dahl E: Prognostic relevance of
Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter
methylation in human breast cancer. BMC Cancer. 9:2172009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
You A, Fokas E, Wang LF, He H, Kleb B,
Niederacher D, Engenhart-Cabillic R and An HX: Expression of the
Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial
ovarian cancer. J Cancer Res Clin Oncol. 137:621–627. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van der Meide WF, Snellenberg S, Meijer
CJ, Baalbergen A, Helmerhorst TJ, van der Sluis WB, Snijders PJ and
Steenbergen RD: Promoter methylation analysis of WNT/β-catenin
signaling pathway regulators to detect adenocarcinoma or its
precursor lesion of the cervix. Gynecol Oncol. 123:116–122.
2011.
|
|
19
|
Götze S, Wolter M, Reifenberger G, Müller
O and Sievers S: Frequent promoter hypermethylation of Wnt pathway
inhibitor genes in malignant astrocytic gliomas. Int J Cancer.
126:2584–2593. 2010.PubMed/NCBI
|
|
20
|
Pannone G, Bufo P, Santoro A, Franco R,
Aquino G, Longo F, Botti G, Serpico R, Cafarelli B, Abbruzzese A,
Caraglia M, Papagerakis S and Lo Muzio L: WNT pathway in oral
cancer: epigenetic inactivation of WNT-inhibitors. Oncol Rep.
24:1035–1041. 2010.PubMed/NCBI
|
|
21
|
Laxmidevi LB, Angadi PV, Pillai RK and
Chandreshekar C: Aberrant β-catenin expression in the histologic
differentiation of oral squamous cell carcinoma and verrucous
carcinoma: an immunohistochemical study. J Oral Sci. 52:633–640.
2010.
|
|
22
|
Yu Z, Weinberger PM, Provost E, Haffty BG,
Sasaki C, Joe J, Camp RL, Rimm DL and Psyrri A: beta-Catenin
functions mainly as an adhesion molecule in patients with squamous
cell cancer of the head and neck. Clin Cancer Res. 11:2471–2477.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iwai S, Yonekawa A, Harada C, Hamada M,
Katagiri W, Nakazawa M and Yura Y: Involvement of the Wnt-β-catenin
pathway in invasion and migration of oral squamous carcinoma cells.
Int J Oncol. 37:1095–1103. 2010.
|
|
24
|
Tenbaum SP, Ordóñez-Morán P, Puig I,
Chicote I, Arqués O, Landolfi S, Fernández Y, Herance JR, Gispert
JD, Mendizabal L, Aguilar S, Ramón y Cajal S, Schwartz S Jr,
Vivancos A, Espín E, Rojas S, Baselga J, Tabernero J, Muñoz A and
Palmer HG: β-catenin confers resistance to PI3K and AKT inhibitors
and subverts FOXO3a to promote metastasis in colon cancer. Nat Med.
18:892–901. 2012.
|
|
25
|
Ishida-Takagishi M, Enomoto A, Asai N,
Ushida K, Watanabe T, Hashimoto T, Kato T, Weng L, Matsumoto S,
Asai M, Murakumo Y, Kaibuchi K, Kikuchi A and Takahashi M: The
Dishevelled-associating protein Daple controls the non-canonical
Wnt/Rac pathway and cell motility. Nat Commun. 3:8592012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y
and Namba M: A REIC gene shows down-regulation in human
immortalized cells and human tumor-derived cell lines. Biochem
Biophys Res Commun. 268:20–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kawauchi K, Watanabe M, Kaku H, Huang P,
Sasaki K, Sakaguchi M, Ochiai K, Huh NH, Nasu Y and Kumon H:
Preclinical safety and efficacy of in situ REIC/Dkk-3 gene therapy
for prostate cancer. Acta Med Okayama. 66:7–16. 2012.PubMed/NCBI
|
|
28
|
Edamura K, Nasu Y, Takaishi M, Kobayashi
T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T,
Watanabe M, Huh NH and Kumon H: Adenovirus-mediated REIC/Dkk-3 gene
transfer inhibits tumor growth and metastasis in an orthotopic
prostate cancer model. Cancer Gene Ther. 14:765–772. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kawasaki K, Watanabe M, Sakaguchi M,
Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH,
Kumon H and Date H: REIC/Dkk-3 overexpression downregulates
P-glycoprotein in multidrug-resistant CF7/ADR cells and induces
apoptosis in breast cancer. Cancer Gene Ther. 16:65–72. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tanimoto R, Abarzua F, Sakaguchi M,
Takaishi M, Nasu Y, Kumon H and Nuh NH: REIC/Dkk-3 as a potential
gene therapeutic agent against human testicular cancer. Int J Mol
Med. 19:363–368. 2007.PubMed/NCBI
|
